Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zevalin + BEAM + ASCT in Relapsed B-Cell Lymphoma
NCT00695409Phase 2Completed
- Sponsor
- City of Hope
- Start
- Mar 2008
- Primary completion
- Mar 2017
- Countries
- 1
01
Overview
Phase 2, open-label trial of ibritumomab tiuxetan in B-cell non-Hodgkin lymphoma, sponsored by City of Hope. Started Mar 2008; status: completed.
02
Drugs
ibritumomab tiuxetan
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00695409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00695409.